FDA Authorizes First Emergency Use Of A COVID-19 Antibody Drug

Eli Lilly’s experimental treatment, bamlanivimab, is a monoclonal antibody therapy, and is cleared for those 12 and older with mild-to-moderate coronavirus cases.